title: Low-dose opioids should be considered for symptom relief also in advanced chronic obstructive pulmonary disease (COPD).
authors.affiliation: Division of Respiratory Medicine & Allergology, Department of Clinical Sciences, Lund University, Lund, Sweden Discipline, Palliative and Supportive Services, Flinders University, Adelaide, South Australia, Australia.
authors.forename: Magnus
authors.initials: M
authors.lastname: Ekström
authors.affiliation: Uppsala Clinical Research Center, Uppsala University Hospital, Uppsala, Sweden.
authors.forename: Anna
authors.initials: A
authors.lastname: Bornefalk-Hermansson
authors.affiliation: Division of Medical Oncology, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
authors.forename: Amy
authors.initials: A
authors.lastname: Abernethy
authors.affiliation: Discipline, Palliative and Supportive Services, Flinders University, Adelaide, South Australia, Australia.
authors.forename: David
authors.initials: D
authors.lastname: Currow
mesh_terms: D000701:Analgesics, Opioid / Q000009:adverse effects*; D001569:Benzodiazepines / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*
chemical_list: D000701:Analgesics, Opioid; D001569:Benzodiazepines